These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|
¨
|
TRANSACTION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|
Nevada
|
88-0126444
|
|
|
(State of Other Jurisdiction of Incorporation or
Organization)
|
(I.R.S. Employer Identification Number)
|
|
|
c/o
Paragon Capital LP
110
East 59
th
Street, 29
th
Floor
New
York, NY
|
10022
|
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
|
Large
accelerated filer
|
o
|
Accelerated
filer
|
o
|
|
Non-accelerated
filer
|
o
|
Smaller
reporting company
|
x
|
|
Page
|
||
|
PART
I – FINANCIAL INFORMATION
|
1 | |
|
Item
1.
|
Financial
Statements
|
1 |
|
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Plan of
Operations
|
9 |
|
Item
3.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
11 |
|
Item
4T.
|
Controls
and Procedures
|
12 |
|
PART
II – OTHER INFORMATION
|
12 | |
|
Item
1.
|
Legal
Proceedings
|
12 |
|
Item
1A.
|
Risk
Factors
|
12 |
|
Item
2.
|
Unregistered
Sale of Equity Securities and Use of Proceeds
|
12 |
|
Item
3.
|
Defaults
Upon Senior Securities
|
13 |
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
13 |
|
Item
5.
|
Other
Information
|
13 |
|
Item
6.
|
Exhibits
|
13 |
|
SIGNATURES
|
14 | |
|
PREVENTION
INSURANCE.COM
|
||||||||
|
|
||||||||
|
ASSETS
|
||||||||
|
January
31, 2010
|
April
30, 2009
|
|||||||
|
(Unaudited)
|
(Audited)
|
|||||||
|
Current assets
|
||||||||
|
Cash
|
$ | 74,381 | $ | 4,253 | ||||
|
Total
current assets
|
74,381 | 4,253 | ||||||
|
Total
assets
|
$ | 74,381 | $ | 4,253 | ||||
|
LIABILITIES
AND STOCKHOLDERS' EQUITY (DEFICIT)
|
||||||||
|
Current liabilities
|
||||||||
|
Accounts
payable
|
$ | 3,425 | $ | 8,754 | ||||
|
Due to
shareholder
|
- | 400,000 | ||||||
|
Total
current liabilities
|
3,425 | 408,754 | ||||||
|
Total
liabilities
|
$ | 3,425 | $ | 408,754 | ||||
|
Commitments
and contingencies
|
- | - | ||||||
|
Stockholders' deficit
|
||||||||
|
Preferred
stock, par value $0.001; 8,000,000 shares authorized;
|
- | - | ||||||
|
zero
shares issued
|
||||||||
|
Preferred
stock, par value $0.01; 2,000,000 shares authorized:;
|
- | - | ||||||
|
zero
shares issued
|
||||||||
|
Common
stock, $0.01 par value; 100,000,000 shares
authorized;
|
||||||||
|
99,472,933
shares as of January 31, 2010 and 97,872,933 shares
|
||||||||
|
as
of April 30, 2009, issued and outstanding, respectively
|
994,730 | 978,730 | ||||||
|
Additional
paid in capital
|
3,194,226 | 2,720,226 | ||||||
|
Treasury
stock, 24,142 shares, at cost
|
(52,954 | ) | (52,954 | ) | ||||
|
Accumulated
deficit
|
(4,065,046 | ) | (4,050,503 | ) | ||||
|
Total
stockholders' equity (deficit)
|
70,956 | (404,501 | ) | |||||
|
Total
liabilities and stockholders' equity (deficit)
|
$ | 74,381 | $ | 4,253 | ||||
|
The
financial information presented herein has been prepared by
management
|
|
|
without
audit by independent certified public accountants
|
|
|
The
accompanying notes are an integral part of these financial
statements.
|
|
|
PREVENTION
INSURANCE.COM
|
||||||||||||||||
|
|
||||||||||||||||
|
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||
|
January
31,
|
January
31,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
|||||||||||||
|
Revenue
|
$ | - | $ | - | $ | - | $ | - | ||||||||
|
Operating
expenses
|
||||||||||||||||
|
General
and administrative
|
3,599 | 10,361 | 14,543 | 26,866 | ||||||||||||
|
Total
operating expenses
|
3,599 | 10,361 | 14,543 | 26,866 | ||||||||||||
|
Operating
(loss) from continuing operations
|
(3,599 | ) | (10,361 | ) | (14,543 | ) | (26,866 | ) | ||||||||
|
Other
income (expense)
|
||||||||||||||||
|
Gain
on contingency
|
- | - | - | 10,000 | ||||||||||||
|
Total
other income (expense)
|
- | - | - | 10,000 | ||||||||||||
|
(Loss)
from continuing operations
|
(3,599 | ) | (10,361 | ) | (14,543 | ) | (16,866 | ) | ||||||||
|
Discontinued
operations
|
||||||||||||||||
|
Gain
on disposal of operating activity
|
59,914 | 59,914 | ||||||||||||||
|
(Loss)
on discontinued operations
|
- | (24,437 | ) | (22,750 | ) | |||||||||||
|
Income
from discontinued operations
|
- | 35,477 | - | 37,164 | ||||||||||||
|
Net
income (loss)
|
$ | (3,599 | ) | $ | 25,116 | $ | (14,543 | ) | $ | 20,298 | ||||||
|
Earnings
per common share - basic and dilutive:
|
||||||||||||||||
|
Income
(loss) from continuing operations
|
$ | Nil | $ | Nil | $ | Nil | $ | Nil | ||||||||
|
Income
(loss) from discontinued operations
|
$ | Nil | $ | Nil | $ | Nil | $ | Nil | ||||||||
|
Net
income (loss)
|
$ | Nil | $ | Nil | $ | Nil | $ | Nil | ||||||||
|
Weighted
average common shares outstanding
|
||||||||||||||||
|
Basic
and dilutive
|
99,472,933 | 97,872,933 | 98,240,348 | 97,872,933 | ||||||||||||
|
Nil
= < $.01
|
||||||||||||||||
|
The
financial information presented herein has been prepared by
management
|
||||||||||||||||
|
without
audit by independent certified public accountants
|
||||||||||||||||
|
The
accompanying notes are an integral part of these financial
statements
|
||||||||||||||||
|
|
||||||||
|
Nine
Months Ended
|
||||||||
|
January
31,
|
||||||||
|
2010
|
2009
|
|||||||
|
(Unaudited)
|
(Unaudited)
|
|||||||
|
Cash flows from operating
activities:
|
||||||||
|
Net
income (loss)
|
$ | (14,543 | ) | $ | 20,298 | |||
|
Adjustments
to reconcile net loss
|
||||||||
|
to
net cash (used in) operating activities:
|
||||||||
|
Gain
on disposal of operating activity
|
- | (59,914 | ) | |||||
|
Gain
on contingency
|
- | (10,000 | ) | |||||
|
(Increase)
decrease in assets:
|
||||||||
|
Prepaid
expenses
|
- | (2,000 | ) | |||||
|
Increase
(decrease) in liabilities:
|
||||||||
|
Accounts
payable
|
(5,329 | ) | - | |||||
|
Net
cash flows (used in) operating activities
|
(19,872 | ) | (51,616 | ) | ||||
|
Cash flows from investing
activities:
|
||||||||
|
Change
in net liabilities spun-off
|
- | 1,428 | ||||||
|
Net
cash flows provided by investing activities
|
- | 1,428 | ||||||
|
Cash flows from financing
activities:
|
||||||||
|
Proceeds
from issuance of warrants
|
90,000 | 45,000 | ||||||
|
Net
cash flows provided by financing activities
|
90,000 | 45,000 | ||||||
|
Net
increase (decrease) in cash and cash equivalents
|
70,128 | (5,187 | ) | |||||
|
Cash
and cash equivalents, beginning of period
|
4,253 | 9,440 | ||||||
|
Cash
and cash equivalents, end of period
|
$ | 74,381 | $ | 4,253 | ||||
|
Supplemental cash flow
disclosures:
|
||||||||
|
Interest
paid
|
$ | - | $ | - | ||||
|
Income
taxes paid
|
$ | - | $ | - | ||||
|
Supplemental non-cash investing and financing
activities:
|
||||||||
|
Conversion
of $400,000 note payable for 1,600,000 shares of restricted common stock -
September 2009
|
||||||||
|
The
financial information presented herein has been prepared by
management
|
||||||||
|
without
audit by independent certified public accountants
|
||||||||
|
The
accompanying notes are an integral part of these condensed financial
statements.
|
||||||||
|
The
Company does not expect any of the recently issued accounting
pronouncements to have a material impact on its financial condition or
results of operations.
|
|
Nine
Months Ended
|
||||||||
|
January
31, 2010
|
||||||||
|
Exercise
|
||||||||
|
Shares
|
Price
|
|||||||
|
Warrants
outstanding and exercisable -
|
||||||||
|
beginning
of the period - May 01, 2009
|
55,000,000 | $ | 0.008 | |||||
|
Warrants
granted:
|
||||||||
|
December
31, 2009
|
75,000,000 | $ | 0.005 | |||||
|
May
29, 2009
|
15,000,000 | $ | 0.005 | |||||
|
Warrants
outstanding and exercisable -
|
||||||||
|
end
of period - January 31, 2010
|
145,000,000 | $ | 0.006 | |||||
|
Weighted
average fair value of warrants
|
||||||||
|
granted
end of period
|
$ | 875,000 | ||||||
|
Weighted
|
Average
|
|||||||||||||||||
|
Range
of
|
Number
|
Remaining
|
Weighted
Average
|
Life
Exercise
|
||||||||||||||
|
Exercise
|
Prices
|
Outstanding
|
Contractual
|
Price
|
||||||||||||||
| $ | 0.005 - 0.01 | $ | 0.006 | 145,000,000 | 3 years | $ | 0.006 | |||||||||||
|
•
|
discuss
our future expectations;
|
|
•
|
contain
projections of our future results of operations or of our financial
condition; and
|
|
•
|
state
other "forward-looking"
information.
|
|
●
|
We
were unable to maintain any segregation of duties within our business
operations due to our reliance on a single individual fulfilling the role
of sole officer and director. While this control deficiency did not result
in any audit adjustments to our 2008 through 2010 interim or annual
financial statements, it could have resulted in a material misstatement
that might have been prevented or detected by a segregation of duties.
Accordingly we have determined that this control deficiency constitutes a
material weakness.
|
|
Exhibit No.
|
|
Description
|
|
10.1
|
Agreement,
dated March 8, 2010 between Prevention Insurance.com, Paragon Capital LP,
and Mr. Scott Goldsmith
|
|
|
10.2
|
Warrant
Extension Agreement, dated March 8, 2010 between Prevention Insurance.com,
Paragon Capital LP, and Mr. Scott Goldsmith
|
|
|
31.1
|
|
Certification
by Alan P. Donenfeld, the Principal Executive Officer and Principal
Financial Officer of Prevention Insurance.com, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act
of 2002
|
|
32.1
|
|
Certification
by Alan P. Donenfeld, the Principal Executive Officer and Principal
Financial Officer of Prevention Insurance.com, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002
|
| PREVENTION INSURANCE.COM | |||
|
|
/s/ Alan P. Donenfeld | ||
|
Alan
P. Donenfeld
Chief
Executive Officer, President and Chairman
(Principal
Executive Officer)
(Principal
Financial/Accounting Officer)
|
|||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|